XOMA Royalty PFD Update: Going Back To My Original Sell Ratings
Source: SeekingAlpha
2025-10-03 08:00:00 ET
Introduction
XOMA Royalty Corporation ( XOMA ) offers preferred stock investors the opportunity to diversify their holdings away from mREITs and banks, the main issuers of these securities, without having to own ETFs or CEFs to accomplish that task. Along with a brief overview of XOMA Corporation, I will review both preferred stocks available:
Read the full article on Seeking Alpha
For further details see:
XOMA Royalty PFD Update: Going Back To My Original Sell Ratings
XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
NASDAQ: XOMAP
XOMAP Trading
0.0% G/L:
$25.75 Last:
145 Volume:
$25.75 Open:
XOMAP Latest News
February 09, 2026 09:53:00 am
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
December 30, 2025 07:30:00 am
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
December 05, 2025 09:00:00 am
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
XOMAP Stock Data
$290,610,822
10,055,080
N/A
24
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
